CA Safe Injection Site Bill Killed, Good Polls on MS MedMJ and DC Natural Psychedelic Initiatives, More… (9/3/20)

There are good polling results for medical marijuana in Mississippi and a natural psychedelic initiative in Washington, DC; Pennsylvania's top elected officials call for marijuana legalization, and more.

Marijuana Policy.

Pennsylvania Governor, Lt. Governor Call on Legislature to Legalize Marijuana. Governor Tom Wolf (D) and Lt. Governor John Fetterman (D) called Thursday for the General Assembly to legalize the use of recreational marijuana in Pennsylvania. According to the governor's office, legalization will provide a revenue stream that will help the state's economic recovery from the coronavirus pandemic.

Medical Marijuana

Mississippi Poll Has Very High Support for Medical Marijuana Initiative. Polling firm FM3 Research recently conducted a survey of state voters and found a whopping 81% supported legalizing the use of medical marijuana. Voters will have the chance to vote on two competing initiatives, one championed by Mississippians for Compassionate Care, and another watered-down created by state legislators. The survey found voters preferred the original initiative, Initiative 65, over the watered-down one, Alternative 65A.

Harm Reduction

California Safe Injection Site Bill Killed. Legislative leaders in Sacramento last week killed Assembly Bill 362, which would have allowed the cities of Oakland and San Francisco to establish safe injection sites in a bid to reduce drug overdoses. The bill had already passed the Assembly but was shelved in the Senate.

Psychedelics

DC Poll Has Solid Support for Psychedelic Decriminalization Initiative. A new poll of DC residents has support for Initiative 81 at 60%, up nine points since the poll was last conducted in April. The measure would make natural psychedelics the lowest law enforcement priority in the nation's capital.

International

Australian Officials Ponder Allowing MDMA, Magic Mushrooms for Mental Health Treatment. The country's medicines regulator, the Therapeutic Goods Administration, is seeking feedback on a proposal to legalize MDMA and psilocybin—the active ingredient in magic mushrooms—for mental health treatment purposes. Mind Medicine Australia, a non-profit that advocates for new treatments for depression and PTSD has asked the regulator to allow psychiatrists to use MDMA and the hallucinogenic psilocybin in therapy sessions.